Economy
Abu Dhabi Billionaire Considers IPO of Pharmaceuticals Business

(Bloomberg) –Abu Dhabi billionaire Bavaguthu Raghuram Shetty, the founder of two London-listed companies, is considering selling shares in his pharmaceuticals business.
“It makes sense to take it down this path where an IPO as an option is a good thing,” said Binay Shetty, chief executive officer of BRS Ventures. Work on the potential share sale in Neopharma is at an initial stage, he said.
Shetty said the business could be listed in the next three years but that there was no decision on whether to return to London again. “We want to work on this for the next six months internally.”
Shetty’s father founded London-traded NMC Health Plc and Finablr Plc, the payments processor that went public in May. Neopharma currently operates in about 50 markets, including Middle East, Africa and Asia.
-
News1 month ago
Offer Price, Overview, Investors: Here’s Everything You Need to Know About Asyad Shipping’s Mega IPO
-
OER Magazines1 month ago
OER, February 25
-
Automotive2 months ago
[REVIEW] A Legend Reinvented: The Nissan Patrol Y63 Blends Heritage with Modern Mastery
-
Alamaliktistaad Magazines1 month ago
Al-iktisaad, February 2025
-
Energy1 month ago
Dubai Supreme Council of Energy Unveils 5th Emirates Energy Award 2023–2025 in Muscat
-
News2 months ago
Oil Prices Rise as Investors Assess New US Tariff Threats
-
News2 months ago
Middle East Emerging as a Key Destination for Sports Tourism
-
News4 weeks ago
Shell Oman Marketing Company Hosts the 1st Lubricants Technology Conference in Muscat